Alpha-Amylase Variants Derived From The Alpha Amylase Of Cytophaga Sp.Amylase (Cspamy2).

Patent No. EP2859097 (titled "Alpha-Amylase Variants Derived From The Alpha Amylase Of Cytophaga Sp.Amylase (Cspamy2).") was filed by Danisco on Jun 3, 2013. The application was issued on May 14, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
NOVOZYMESNov 3, 2021POTTER CLARKSON

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2859097

DANISCO
Application Number
EP13729864A
Filing Date
Jun 3, 2013
Status
Patent Maintained As Amended
Apr 11, 2025
Publication Date
May 14, 2025